Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001735276-23-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-23 | ALNY | PYOTT DAVID E I | Dir | M - OptEx | $0.00 | +136 | 136 | New | $0 |
| D | 2023-02-27 | 2023-02-23 | ALNY | PYOTT DAVID E I | Dir | M - OptEx | $0.00 | -136 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | M | A | 136 | $0.00 | 136 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2023-02-23 | M | D | 136 | $0.00 | 0 | D | — · — to — | 136 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. (F3) This award vested on February 23, 2023, the first anniversary of the grant date. |